发明申请
US20210209299A1 GOAL-ORIENTED CONVERSATION WITH CODE-MIXED LANGUAGE TO DETECT ADVERSE REACTION TO MEDICATION
有权
基本信息:
- 专利标题： GOAL-ORIENTED CONVERSATION WITH CODE-MIXED LANGUAGE TO DETECT ADVERSE REACTION TO MEDICATION
- 申请号：US16732708 申请日：2020-01-02
- 公开(公告)号：US20210209299A1 公开(公告)日：2021-07-08
- 发明人： Victor Abayomi Akinwande , Celia Cintas , Aisha Walcott , William Ogallo , Sekou Lionel Remy
- 申请人： International Business Machines Corporation
- 申请人地址： US NY Armonk
- 专利权人： International Business Machines Corporation
- 当前专利权人： International Business Machines Corporation
- 当前专利权人地址： US NY Armonk
- 主分类号： G06F40/20
- IPC分类号： G06F40/20 ; G06N3/04
摘要：
A computer system may create a language model corpus including multilingual alignment for training a combined language model and train (or pre-train) the combined language model. The computer system may create an adverse medication reaction corpus to include adverse medication reaction utterances and label an N-gram of an utterance in the adverse medication reaction utterances as a response to query, for multiple N-grams. The computer system may generate a code-mixed utterance model to perform code-mixed utterances in a turn by turn dialogue, by at least adding additional output layer including at least a start vector, language vector, and a query vector including at least the labeled N-gram, which are additional to the combined language model's predicted next words.
公开/授权文献:
- US11769004B2 Goal-oriented conversation with code-mixed language 公开/授权日：2023-09-26